RM 49 is a mitomycin C analogue that has proven to have in vitro antitumor activity. References: Horiuchi N, Nakagawa K, Sasaki Y, Minato K, Fujiwara Y, Nezu K, Ohe Y, Saijo N. In vitro antitumor activity of mitomycin C derivative (RM-49) and new anticancer antibiotics (FK973) against lung cancer cell lines determined by tetrazolium dye (MTT) assay. Cancer Chemother Pharmacol. 1988;22(3):246-50. PubMed PMID: 2842080.

纯度：≥98%

CAS：113785-48-1